⌘K

Login Start Free

Home/Filings/4/0000950170-24-010943

4//SEC Filing

Gergen Mark J 4

Accession 0000950170-24-010943

CIK 0001661460other

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 8:51 PM ET

Size

4.8 KB

Accession

0000950170-24-010943

Insider Transaction Report

Form 4

Period: 2024-02-01

Poseida Therapeutics, Inc.PSTX

DirectorExecutive Chairman

Transactions

Tax Payment
Common Stock
2024-02-01$3.41/sh−47,162$160,822→ 685,448 total

Footnotes (1)

[F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2022.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Poseida Therapeutics, Inc.

CIK 0001661460

Entity typeother

Related Parties

1

filerCIK 0001373110

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 8:51 PM ET
Size: 4.8 KB

View on SEC.gov